logo

For the Inventor, By the Inventor

Berkeley, CA, United States of America

Biotime, Inc.

USPTO Granted Patents = 35

% Expired Patents = 11.4



Trademarks = 7

Forward Citations = 725

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Hal Sternberg (32 out of 40 patents)

silverMedal Paul E Segall (31 out of 33 patents)

bronzeMedal Harold D Waitz (31 out of 34 patents)

4.  Judith M Segall (23 out of 23 patents)

5.  Bruce Cohen (4 out of 4 patents)

6.  Michael D West (3 out of 46 patents)

7.  Karen B Chapman (2 out of 33 patents)

8.  Dana Larocca (1 out of 5 patents)

9.  Paola A Bignone (1 out of 3 patents)

10.  Thomas Zarembinski (1 out of 1 patent)

11.  Isaac Erickson (1 out of 1 patent)

12.  Nathaniel Doty (1 out of 1 patent)

13.  Evan Y Snyder (1 out of 11 patents)

14.  Stanley T Carmichael (4 patents)

15.  Andrew N Clarkson (1 patent)


Core Competencies:
Progenitor Cell Lines
Hyaluronan Hydrogels
Transcriptional Regulation
Chondrogenesis
Perfusion Applications
Plasma Expanders
Blood Substitutes
Microcannula
Physiologically Acceptable Solutions
Plasma-Like Solution
Methods of Use
Aqueous Solutions

35 patents:

1. 10227561 - Methods and compositions for targeting progenitor cell lines (2019-03-12),
2. 10137199 - Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione (2018-11-27),
3. 9732128 - Methods of modifying transcriptional regulatory networks in stem cells (2017-08-15),
4. 8685386 - Methods and compositions for in vitro and in vivo chondrogenesis (2014-04-01),
5. 7943292 - Physiologically acceptable aqueous solutions and methods for their use (2011-05-17),
6. 7503913 - Methods and compositions for use in perfusion applications (2009-03-17),
7. 6991624 - Methods and compositions for use in perfusion applications (2006-01-31),
8. 6680305 - Physiologically acceptable aqueous solutions and methods for their use (2004-01-20),
9. 6627393 - Solutions for use as plasma expanders and substitutes (2003-09-30),
10. 6589223 - Method and compositions for use in perfusion applications (2003-07-08),
11. 6506549 - Plasma expanders and blood substitutes (2003-01-14),
12. 6444418 - Plasma-like solution (2002-09-03),
13. 6410218 - Plasma-like solution (2002-06-25),
14. 6406839 - Methods for using a plasma-like solution (2002-06-18),
15. 6387612 - Method of preparing a terminally heat sterilized plasma-like solution (2002-05-14),
Company Overview
Biotime, Inc. is a biotechnology company based in Berkeley, California, specializing in the development of innovative solutions for regenerative medicine and cellular therapies. The organization focuses on advancing technologies related to stem cell research, cellular rejuvenation, and biopreservation. By leveraging its expertise in these domains, Biotime aims to address significant challenges in aging and tissue repair, contributing to the broader field of health and longevity. Its commitment to scientific advancement positions it as a key player in the biotechnology landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Biotime, Inc. USPTO Patent Assignee Logo
35 Patents

#20 in Berkeley, CA

#2,311 in California

#9,756 in US

#19,181 in the World

Berkeley, CA (US)
Berkeley, CA, United States of America

Biotime, Inc.

Forward Citations = 725

13 inventors:

goldMedal Hal Sternberg (32 out of 40 patents)

silverMedal Paul E Segall (31 out of 33 patents)

bronzeMedal Harold D Waitz (31 out of 34 patents)

4.  Judith M Segall (23 out of 23 patents)

5.  Bruce Cohen (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biotime, Inc.. Retrieved from https://idiyas.com/company/biotime

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…